HSP90AB1 and glioblastoma: The antiproliferative and cytotoxic effects of 17-AAG against GBM cell lines were significantly potentiated by the simultaneous silencing of HSP27, suggesting synergistic antitumor benefits of concomitant HSP27 knockdown and HSP90 inhibition [36].